Literature DB >> 2779563

Translational initiation factor expression and ribosomal protein gene expression are repressed coordinately but by different mechanisms in murine lymphosarcoma cells treated with glucocorticoids.

S Huang1, J W Hershey.   

Abstract

P1798 murine lymphosarcoma cells cease to proliferate upon exposure to 10(-7) M dexamethasone and exhibit a dramatic inhibition of rRNA and ribosomal protein synthesis (O. Meyuhas, E. Thompson, Jr., and R. P. Perry, Mol. Cell Biol. 7:2691-2699, 1987). These workers demonstrated that ribosomal protein synthesis is regulated primarily at the level of translation, since dexamethasone did not alter mRNA levels but shifted the mRNAs from active polysomes into inactive messenger ribonucleoproteins. We have examined the effects of dexamethasone on the biosynthesis of initiation factor proteins in the same cell line. The relative protein synthesis rates of eIF-4A and eIF-2 alpha were inhibited by about 70% by the hormone, a reduction comparable to that for ribosomal proteins. The mRNA levels of eIF-4A, eIF-4D, and eIF-2 alpha also were reduced by 60 to 70%, indicating that synthesis rates are proportional to mRNA concentrations. Analysis of polysome profiles showed that the average number of ribosomes per initiation factor polysome was only slightly reduced by dexamethasone, and little or no mRNA was present in messenger ribonucleoproteins. The results indicate that initiation factor gene expression is coordinately regulated with ribosomal protein synthesis but is controlled primarily by modulating mRNA levels rather than mRNA efficiency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779563      PMCID: PMC362428          DOI: 10.1128/mcb.9.9.3679-3684.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Three abundance classes in HeLa cell messenger RNA.

Authors:  J O Bishop; J G Morton; M Rosbash; M Richardson
Journal:  Nature       Date:  1974-07-19       Impact factor: 49.962

2.  Rapid alterations in initiation rate and recruitment of inactive RNA are temporally correlated with S6 phosphorylation.

Authors:  R Duncan; E H McConkey
Journal:  Eur J Biochem       Date:  1982-04

3.  Initiation factor and ribosome levels are coordinately controlled in Escherichia coli growing at different rates.

Authors:  J G Howe; J W Hershey
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

4.  Immunochemical characterization of mammalian protein synthesis initiation factors.

Authors:  L J Meyer; S C Milburn; J W Hershey
Journal:  Biochemistry       Date:  1982-08-31       Impact factor: 3.162

5.  Unco-ordinate regulation of ribosomal RNA and ribosomal protein synthesis during L6E9 myoblast differentiation.

Authors:  K S Krauter; R Soeiro; B Nadal-Ginard
Journal:  J Mol Biol       Date:  1980-09-15       Impact factor: 5.469

6.  Evidence for control of protein synthesis in HeLa cells via the elongation rate.

Authors:  P J Nielsen; E H McConkey
Journal:  J Cell Physiol       Date:  1980-09       Impact factor: 6.384

7.  Identification and quantitation of levels of protein synthesis initiation factors in crude HeLa cell lysates by two-dimensional polyacrylamide gel electrophoresis.

Authors:  R Duncan; J W Hershey
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

8.  Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA.

Authors:  A J Minty; M Caravatti; B Robert; A Cohen; P Daubas; A Weydert; F Gros; M E Buckingham
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

9.  Dexamethasone decreases the amounts of type I procollagen mRNAs in vivo and in fibroblast cell cultures.

Authors:  K M Sterling; M J Harris; J J Mitchell; T A DiPetrillo; G L Delaney; K R Cutroneo
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

10.  Sequence determination and cDNA cloning of eukaryotic initiation factor 4D, the hypusine-containing protein.

Authors:  Z Smit-McBride; T E Dever; J W Hershey; W C Merrick
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

View more
  7 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes.

Authors:  C M Smith; J A Steitz
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

3.  Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation.

Authors:  H Tang; E Hornstein; M Stolovich; G Levy; M Livingstone; D Templeton; J Avruch; O Meyuhas
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells.

Authors:  S Shama; D Avni; R M Frederickson; N Sonenberg; O Meyuhas
Journal:  Gene Expr       Date:  1995

5.  Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control.

Authors:  S Levy; D Avni; N Hariharan; R P Perry; O Meyuhas
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Coordinate translational regulation in the syntheses of elongation factor 1 alpha and ribosomal proteins in Xenopus laevis.

Authors:  F Loreni; A Francesconi; F Amaldi
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

7.  On the functions of the h subunit of eukaryotic initiation factor 3 in late stages of translation initiation.

Authors:  Byung-Hoon Kim; Xue Cai; Justin N Vaughn; Albrecht G von Arnim
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.